ArticleBlood advances2026

Allogeneic HSCT may improve survival in advanced extranodal NK/T-cell lymphoma: a single-center retrospective study.

Zhihui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.